Lung Cancer Screening Program in Mexico
Lung Cancer Early Detection With Low-dose Computed Tomography in High-risk Individuals: Experience in Mexico
Instituto Nacional de Cancerologia de Mexico
1,000 participants
Mar 24, 2022
OBSERVATIONAL
Conditions
Summary
This prospective study aims to detect early-stage lung cancer using low-dose computed tomography (LDCT) in Mexicans aged 50 or older who are current or former heavy smokers, non-smokers exposed to significant wood smoke, or diagnosed with COPD. Annual LDCT, spirometry, and serum biomarker tests will be conducted over 3 years, and a follow-up lasting up to 10 years.
Eligibility
Inclusion Criteria5
- Eligible participants over fifty years old and one of the next criteria:
- Current smokers (\>20 pack-years)
- Former smokers (\>20 pack-years) who have quit within the past 15 years,
- Non-smokers exposed to wood smoke more than 100 hours/year
- Patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD).
Exclusion Criteria6
- Subjects who cannot be examined by tomography due to physical limitations such as weight.
- History of any type of cancer within the last five years, except non-melanoma skin cancer.
- Symptoms consistent with some malignant neoplasm.
- People with a poor physical-emotional condition that reduces their life expectancy or does not ensure adherence to the study.
- Elimination Criteria
- • Withdrawal of informed consent
Interventions
Annual LDCT, lung function test (spirometry), anxiety/depression assessments, and serum biomarkers tests over 3 years. Follow-up will continue for 5 and 10 years or until event completion (cancer diagnosis, end of follow-up, or death).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06535451